Literature DB >> 32176442

Performance of prognostic markers in the prediction of wound healing or amputation among patients with foot ulcers in diabetes: A systematic review.

Rachael O Forsythe1, Jan Apelqvist2, Edward J Boyko3, Robert Fitridge4, Joon Pio Hong5, Konstantinos Katsanos6, Joseph L Mills7, Sigrid Nikol8, Jim Reekers9, Maarit Venermo10, R Eugene Zierler11, Nicolaas C Schaper12, Robert J Hinchliffe13.   

Abstract

Clinical outcomes of patients with diabetes, foot ulceration, and peripheral artery disease (PAD) are difficult to predict. The prediction of important clinical outcomes, such as wound healing and major amputation, would be a valuable tool to help guide management and target interventions for limb salvage. Despite the existence of a number of classification tools, no consensus exists as to the most useful bedside tests with which to predict outcome. We here present an updated systematic review from the International Working Group of the Diabetic Foot, comprising 15 studies published between 1980 and 2018 describing almost 6800 patients with diabetes and foot ulceration. Clinical examination findings as well as six non-invasive bedside tests were evaluated for their ability to predict wound healing and amputation. The most useful tests to inform on the probability of healing were skin perfusion pressure ≥ 40 mmHg, toe pressure ≥ 30 mmHg, or TcPO2  ≥ 25 mmHg. With these thresholds, all of these tests increased the probability of healing by greater than 25% in at least one study. To predict major amputation, the most useful tests were ankle pressure < 50 mmHg, ABI < 0.5, toe pressure < 30 mmHg, and TcPO2  < 25 mmHg, which increased the probability of major amputation by greater than 25%. These indicative values may be used as a guide when deciding which patients are at highest risk for poor outcomes and should therefore be evaluated for revascularization at an early stage. However, this should always be considered within the wider context of important co-existing factors such as infection, wound characteristics, and other comorbidities.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  amputation; diabetes; diabetic foot; peripheral artery disease; prognosis; ulcer

Mesh:

Substances:

Year:  2020        PMID: 32176442     DOI: 10.1002/dmrr.3278

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  3 in total

Review 1.  Australian guideline on diagnosis and management of peripheral artery disease: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.

Authors:  Vivienne Chuter; Frank Quigley; Patrik Tosenovsky; Jens Carsten Ritter; James Charles; Jane Cheney; Robert Fitridge
Journal:  J Foot Ankle Res       Date:  2022-07-05       Impact factor: 3.050

2.  Effect of tibial cortex transverse transport in patients with recalcitrant diabetic foot ulcers: A prospective multicenter cohort study.

Authors:  Yan Chen; Xiaofang Ding; Yueliang Zhu; Zhongwei Jia; Yong Qi; Mingyong Chen; Jili Lu; Xiaocong Kuang; Jia Zhou; Yongfeng Su; Yongxin Zhao; William Lu; Jinmin Zhao; Qikai Hua
Journal:  J Orthop Translat       Date:  2022-10-12       Impact factor: 4.889

3.  Utilization of smartphone and tablet camera photographs to predict healing of diabetes-related foot ulcers.

Authors:  Renaid B Kim; Jonathan Gryak; Abinash Mishra; Can Cui; S M Reza Soroushmehr; Kayvan Najarian; James S Wrobel
Journal:  Comput Biol Med       Date:  2020-10-08       Impact factor: 6.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.